Wu et al. developed a panel comprising 5 ccRCC-dysregulates lncRNAs (lncRNA-LET, PVT1, PANDAR, PTENP1, linc00963) able to distinguish between ccRCC patients and healthy controls [113]. This evidence concerns the gene PANDAR and nonpapillary renal cell carcinoma.